BFS
RYTM icon

Bare Financial Services’s Rhythm Pharmaceuticals RYTM Stock Holding History

Bare Financial Services’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.13K Sell
13
-9
-41% -$875 ﹤0.01% 1192
2025
Q4 		$2.35K Buy
22
+4
+22% +$424 ﹤0.01% 807
2025
Q3 		$1.82K Buy
18
+8
+80% +$743 ﹤0.01% 835
2025
Q2 		$632 Buy
+10
New +$612 ﹤0.01% 1051

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Bare Financial Services's RYTM Position: Q1 2026 in Review

Bare Financial Services reduced its Rhythm Pharmaceuticals (RYTM) stake by 41% in Q1 2026, selling an estimated $875 and leaving 13 shares worth $1.13K. The position accounts for ﹤0.01% of the portfolio, ranked #1192.

Bare Financial Services first reported a position in RYTM in Q2 2025 and has held it in 4 quarters since. The position peaked at $2.35K in Q4 2025. 285 funds tracked by Wall St. Rank hold RYTM as of Q1 2026.

  • Bare Financial Services held 13 shares of Rhythm Pharmaceuticals worth $1.13K as of Q1 2026.
  • Bare Financial Services sold 9 Rhythm Pharmaceuticals shares in Q1 2026, an estimated $875.
  • Rhythm Pharmaceuticals made up ﹤0.01% of Bare Financial Services's portfolio in Q1 2026, its #1192 holding.
  • Bare Financial Services first reported a position in Rhythm Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
  • Bare Financial Services's Rhythm Pharmaceuticals position peaked at $2.35K in Q4 2025.
  • 285 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q1 2026.

Based on Bare Financial Services's 13F filing for Q1 2026, filed 14 May 2026.